Suppr超能文献

早期阿尔茨海默病的情感症状与区域性脑tau 负担。

Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease.

机构信息

Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Int J Geriatr Psychiatry. 2021 Jul;36(7):1050-1058. doi: 10.1002/gps.5530. Epub 2021 Mar 15.

Abstract

OBJECTIVE

Neuropsychiatric symptoms (NPS) are often present in individuals with mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia. NPS are associated with structural and functional changes in the brain such as atrophy, regional hypometabolism, and hypoperfusion, considered proxies of neurodegeneration. Our objective was to evaluate the association between NPS and regional cerebral tau burden, a more direct representation of neurodegeneration, in cognitively normal (CN), MCI, and AD dementia individuals.

METHODS

Cross-sectional NPS were assessed using the Neuropsychiatric Inventory (NPI) in 410 CN, 199 MCI, and 61 AD dementia participants who underwent flortaucipir tau positron emission tomography as part of the AD Neuroimaging Initiative (ADNI). Total NPI score and two factors of NPS (affective and hyperactive) were used in analyses. Linear regression models with backward elimination were employed with NPI as dependent variable and regional tau or tau-amyloid interaction as predictor of interest. Covariates included education, age, sex, Rey Auditory Verbal Learning Test Total Learning, and Trail Making Test B.

RESULTS

There were significant associations (p < 0.05) between the NPI variables (total score, Affective factor) and entorhinal and precuneus tau across all participants. These associations were also significant for the tau-amyloid interaction. These effects were significant in cognitively symptomatic participants (MCI and AD dementia), but not in CN participants.

CONCLUSIONS

Increased tau burden in the entorhinal and precuneus cortices was modestly associated with greater NPS in MCI and AD dementia. Further evaluation of NPS and their effect on early-stage AD could aid in finding new interventions and slowing disease progression.

摘要

目的

神经精神症状(NPS)在轻度认知障碍(MCI)和阿尔茨海默病(AD)痴呆患者中经常出现。NPS 与大脑结构和功能变化有关,如萎缩、区域性低代谢和低灌注,被认为是神经退行性变的替代物。我们的目的是评估 NPS 与认知正常(CN)、MCI 和 AD 痴呆个体中区域脑 tau 负担之间的关系,tau 负担是神经退行性变的更直接表现。

方法

在作为 AD 神经影像学倡议(ADNI)一部分接受 flortaucipir tau 正电子发射断层扫描的 410 名 CN、199 名 MCI 和 61 名 AD 痴呆参与者中,使用神经精神病学问卷(NPI)评估横断面 NPS。总 NPI 评分和 NPS 的两个因子(情感和多动)用于分析。采用带有向后消除的线性回归模型,以 NPI 为因变量,以感兴趣的区域 tau 或 tau-淀粉样蛋白相互作用为预测变量。协变量包括教育、年龄、性别、 Rey 听觉言语学习测试总学习和 Trail Making 测试 B。

结果

在所有参与者中,NPI 变量(总分、情感因子)与内嗅皮质和楔前叶 tau 之间存在显著关联(p<0.05)。tau-淀粉样蛋白相互作用也存在显著关联。这些效应在认知症状性参与者(MCI 和 AD 痴呆)中显著,但在 CN 参与者中不显著。

结论

内嗅皮质和楔前叶皮质 tau 负担增加与 MCI 和 AD 痴呆患者的 NPS 增加适度相关。进一步评估 NPS 及其对早期 AD 的影响可能有助于找到新的干预措施并减缓疾病进展。

相似文献

1
Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease.
Int J Geriatr Psychiatry. 2021 Jul;36(7):1050-1058. doi: 10.1002/gps.5530. Epub 2021 Mar 15.
5
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Int Psychogeriatr. 2021 Nov;33(11):1217-1228. doi: 10.1017/S1041610221000934. Epub 2021 Aug 17.
8
Relationship between neuropsychiatric symptoms and Alzheimer's disease pathology: An in vivo positron emission tomography study.
Int J Geriatr Psychiatry. 2021 Apr;36(4):598-605. doi: 10.1002/gps.5459. Epub 2020 Nov 15.
10
Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
Neurology. 2023 Feb 14;100(7):e683-e693. doi: 10.1212/WNL.0000000000201517. Epub 2022 Nov 2.

引用本文的文献

3
Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study.
Am J Geriatr Psychiatry. 2024 Aug;32(8):909-919. doi: 10.1016/j.jagp.2024.01.020. Epub 2024 Jan 28.
6
A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles.
Brain Commun. 2023 Nov 16;6(1):fcad305. doi: 10.1093/braincomms/fcad305. eCollection 2024.
7
Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease.
J Neurol. 2024 Apr;271(4):2067-2077. doi: 10.1007/s00415-023-12131-0. Epub 2023 Dec 19.

本文引用的文献

1
2
Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer's disease: A systematic literature review.
Neurosci Biobehav Rev. 2019 Dec;107:346-359. doi: 10.1016/j.neubiorev.2019.09.014. Epub 2019 Sep 13.
5
Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers.
Exp Mol Med. 2019 May 9;51(5):1-10. doi: 10.1038/s12276-019-0250-2.
6
Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults.
Am J Geriatr Psychiatry. 2019 Aug;27(8):823-834. doi: 10.1016/j.jagp.2019.01.215. Epub 2019 Feb 2.
9
The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.
Ann Neurol. 2019 Feb;85(2):181-193. doi: 10.1002/ana.25395. Epub 2019 Jan 21.
10
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验